Clinical trial Recruiting at 1 site Interventional Ages 18 and up

Healing the palatal donor site after a free gingival graft using a topical steroid

Official title: Impact of Topical Triamcinolone Acetonide on Palatal Wound Healing, Patient Morbidity, and Quality of Life After Free Gingival Graft Surgery: A Randomized Clinical Trial

Run by Kahramanmaras Sutcu Imam University · NCT07409571 · Data updated 2026-11-12

This trial will test whether applying topical triamcinolone acetonide to the palatal donor site helps adults having free gingival graft surgery heal faster and with less pain than a standard collagen sponge.

More Gingival Recession trials

Quick facts

Study typeInterventional
Ages18 Years and up
SexAll
Enrollment55 (estimated)
SponsorKahramanmaras Sutcu Imam University
Academic / other
Locations1 site (Kahramanmaraş, Kahramanmaraş)
StatusRecruiting
StartedOctober 16, 2025
Main results expectedMay 20, 2026
Study endsMay 20, 2026
Registry record updatedMay 22, 2026
Trial IDNCT07409571 on ClinicalTrials.gov

Is this trial a fit for you?

Likely a good fit

Adults aged 18 and older who are systemically healthy (ASA I), have mucogingival deficiencies requiring a free gingival graft, low plaque and bleeding scores, and can attend follow-up visits are ideal candidates.

Probably not a fit

Patients with systemic diseases that impair healing (e.g., diabetes), current smokers, those on recent systemic corticosteroids or immunosuppressants, pregnant or lactating individuals, or anyone with allergy to corticosteroids or collagen materials are unlikely to benefit or are excluded.

A plain-English reading of the study's rules. Only the study team can confirm whether you qualify.

What this trial studies

In this randomized controlled trial, 36 adults needing free gingival grafts are randomly assigned to receive either a collagen hemostatic sponge or topical triamcinolone acetonide at the palatal donor site, with all sites covered by a periodontal dressing. Clinical assessments occur on postoperative days 7, 14, and 30 and include epithelialization testing with hydrogen peroxide bubbling, wound healing scoring using the Landry, Turnbull, and Howley index, and scar evaluation with the modified Manchester Scar Scale. Patient-reported outcomes such as postoperative pain, discomfort, analgesic use, and oral health–related quality of life are recorded alongside clinical measures. The study excludes patients with systemic conditions affecting healing, recent corticosteroid use, tobacco use, pregnancy/lactation, prior palatal surgery, active palatal lesions, or known allergies to study materials.

Why it matters

Potential benefit: If successful, topical triamcinolone could reduce postoperative pain and accelerate epithelialization at the palatal donor site, improving comfort and recovery after free gingival grafts.

How similar studies have gone: Topical corticosteroids have shown benefit for oral inflammatory and ulcerative lesions, but clinical data specifically testing triamcinolone on palatal donor site healing after free gingival grafting are limited or lacking.

Who can join: the full rules

Show full inclusion / exclusion criteria
Inclusion Criteria:

* Adults aged 18 years and older
* Patients presenting with insufficient attached gingiva and/or gingival recession requiring free gingival graft surgery
* Systemically healthy individuals (ASA I)
* Full-mouth plaque score (FMPS) \< 15% and full-mouth bleeding score (FMBS) \< 15% at the time of surgery
* Ability and willingness to provide written informed consent and comply with study procedures

Exclusion Criteria:

* Presence of systemic diseases that may affect wound healing (e.g., diabetes mellitus, immunological disorders)
* Use of systemic corticosteroids, immunosuppressive drugs, or anti-inflammatory medications within the last 3 months
* Current smokers or tobacco users
* Pregnancy or lactation
* History of periodontal surgery at the palatal donor site
* Presence of active infection, ulceration, or pathological lesions at the palatal donor area
* Known allergy or hypersensitivity to corticosteroids, collagen materials, or study-related medications

Where it's running

  • Kahramanmaraş Sütçü İmam University
    Kahramanmaraş, Kahramanmaraş, Turkey (Türkiye)
    Recruiting

Study contacts

Similar studies

Other studies for the same condition or treatment. Recruiting studies are listed first.

How to take part

  1. Review the eligibility criteria above with your treating physician.
  2. Check the official listing on ClinicalTrials.gov for the latest contact details and recruitment status.
  3. Contact the study coordinator or principal investigator to ask for pre-screening. Pre-screening is free and never obligates you to enroll.
Last reviewed 2026-11-14 by the Find a Trial editorial team. Information on this page is for educational purposes and is not medical advice. Always consult qualified healthcare professionals about clinical trial participation.